Related Experiment Video
Updated: Oct 7, 2025

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
Combining experimental and computational techniques to understand and improve dry powder inhalers
V Chaugule1, C Y Wong2, K Inthavong3
1Laboratory for Turbulence Research in Aerospace and Combustion (LTRAC), Department of Mechanical and Aerospace Engineering, Monash University, Clayton Campus, Melbourne, Australia.
Optimizing Dry Powder Inhaler (DPI) performance requires integrating advanced in vitro deposition, particle image velocimetry, and computational modeling. This multidisciplinary approach accelerates drug delivery device development and regulatory approval for commercial success.
Area of Science:
- Pharmaceutical Sciences
- Biomedical Engineering
- Drug Delivery Systems
Background:
- Dry Powder Inhalers (DPIs) are crucial for delivering diverse medications across numerous conditions.
- Each drug-device combination necessitates a unique inhaler design.
- Rapid regulatory approval is vital for market entry and profitability.
Purpose of the Study:
- To outline a combined approach for evaluating and optimizing DPI design and formulation.
- To highlight the importance of integrating experimental and computational methods for efficient development.
- To emphasize the role of multidisciplinary teams and Industry 4.0 in advancing inhaler technology.
Main Methods:
- Utilizing in vitro deposition studies to assess drug aerosolization.
- Employing particle image velocimetry (PIV) to analyze airflow dynamics.
- Implementing computational modeling with physiological geometry for performance prediction.
Main Results:
- Combined methods provide complementary data for inhaler suitability and formulation optimization.
- This integrated approach allows for cost-effective and rapid addressing of development questions.
- Synergistic use of techniques enhances understanding of DPI performance.
Conclusions:
- A multidisciplinary approach combining in vitro, PIV, and computational modeling is essential for optimizing DPIs.
- Skilled teams are key to maximizing the benefits of these advanced techniques.
- The integration of Industry 4.0 principles will further accelerate innovation in inhaler design and usage.
Related Concept Videos
Inhaled Medications
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

